Skip to main content

Swiss National Bank

Bank

Position in NVAX — Novavax Inc

CIK 1582202 ZURICH, V8

Position in NVAX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,617,818
+$402,924 QoQ
Shares Held
277,900
+2.1% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 263 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. NVAX ranks #94 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,617,818 277,900
2026-03-31 $2,214,894 272,100
2025-12-31 $1,828,512 272,100
2025-09-30 $2,450,142 282,600
2025-06-30 $1,743,210 276,700
2025-03-31 $1,790,313 279,300
2024-12-31 $2,278,536 283,400
2024-09-30 $3,129,714 247,800
2024-06-30 $3,137,148 247,800
2024-03-31 $1,008,580 211,000
2023-12-31 $864,960 180,200
2023-09-30 $1,304,648 180,200
2023-06-30 $1,393,868 187,600
2023-03-31 $1,174,635 169,500
2022-12-31 $1,941,892 188,900
2022-09-30 $3,372,460 185,300
2022-06-30 $9,247,114 179,800
2022-03-31 $22,912,515 311,100
2021-12-31 $38,485,830 269,000
2021-09-30 $57,735,835 278,500
2021-06-30 $60,741,891 286,100
2021-03-31 $26,362,474 145,400
2020-12-31 $15,444,135 138,500
2020-09-30 $14,237,190 131,400
2020-06-30 $9,585,250 115,000